Cencora Inc (NYSE:COR)
$ 224.6 0.51 (0.23%) Market Cap: 44.80 Bil Enterprise Value: 47.98 Bil PE Ratio: 24.57 PB Ratio: 41.35 GF Score: 84/100

AmerisourceBergen Corp at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 06:05PM GMT
Release Date Price: $79.79 (+1.75%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right, great. We're going to get started with our next session here with AmerisourceBergen.

I'm Steve Valiquette, the Health Care and Services Analyst here at Barclays. And to my right, we have Steve Collis, the company's Chairman, President, and CEO; and also, Jim Cleary. He has been with the company for a while, but now he's the newest CFO of the company. So gentlemen, welcome.

James F. Cleary
AmerisourceBergen Corporation - CFO & Executive VP

Thanks.

Steven H. Collis
AmerisourceBergen Corporation - Chairman, President & CEO

Thanks, Steve, good to see you.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. So this will be a fireside chat. Certainly a lot of topics going on in the pharmaceutical supply channel as always. It feels like at this conference, brand drug pricing has kind of become

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot